SignalEU/UK

CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis

CHMP recommends EU approval of Roche's Ocrevus for pediatric relapsing MS.

What changed

CHMP recommends EU approval of Roche's Ocrevus for pediatric relapsing MS.

Why it matters

CHMP recommends EU approval of Roche's Ocrevus for pediatric relapsing MS. — impact context not separately stored; see What changed.

Sources